Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 275
of 14Next
1:

Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias.

Jeeninga RE, Jan B, van den Berg H, Berkhout B.

Retrovirology. 2006 Sep 27;3:64.

PMID: 17005036 [PubMed - indexed for MEDLINE]

2:

Construction of a minimal HIV-1 variant that selectively replicates in leukemic derived T-cell lines: towards a new virotherapy approach.

Jeeninga RE, Jan B, van der Linden B, van den Berg H, Berkhout B.

Cancer Res. 2005 Apr 15;65(8):3347-55.

PMID: 15833868 [PubMed - indexed for MEDLINE]

3:

Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution.

Das AT, Klaver B, Centlivre M, Harwig A, Ooms M, Page M, Almond N, Yuan F, Piatak M Jr, Lifson JD, Berkhout B.

Retrovirology. 2008 Jun 5;5:44.

PMID: 18533993 [PubMed - indexed for MEDLINE]

4:

Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat.

Verhoef K, Marzio G, Hillen W, Bujard H, Berkhout B.

J Virol. 2001 Jan;75(2):979-87.

PMID: 11134311 [PubMed - indexed for MEDLINE]

5:

Role of viral regulatory and accessory proteins in HIV-1 replication.

Seelamgari A, Maddukuri A, Berro R, de la Fuente C, Kehn K, Deng L, Dadgar S, Bottazzi ME, Ghedin E, Pumfery A, Kashanchi F.

Front Biosci. 2004 Sep 1;9:2388-413. Review.

PMID: 15353294 [PubMed - indexed for MEDLINE]

6:

Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control.

Zhou X, Vink M, Berkhout B, Das AT.

Retrovirology. 2006 Nov 9;3:82.

PMID: 17094796 [PubMed - indexed for MEDLINE]

7:

Optimization of the Tet-On system for regulated gene expression through viral evolution.

Zhou X, Vink M, Klaver B, Berkhout B, Das AT.

Gene Ther. 2006 Oct;13(19):1382-90. Epub 2006 May 25.

PMID: 16724096 [PubMed - indexed for MEDLINE]

8:

Cell-free HIV-1Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization.

Nagashunmugam T, Friedman HM.

DNA Cell Biol. 1996 May;15(5):353-61.

PMID: 8924209 [PubMed - indexed for MEDLINE]

9:

Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.

Das AT, Klaver B, Harwig A, Vink M, Ooms M, Centlivre M, Berkhout B.

J Virol. 2007 Oct;81(20):11159-69. Epub 2007 Aug 1.

PMID: 17670816 [PubMed - indexed for MEDLINE]

10:

Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region.

Xiao Y, Kuwata T, Miura T, Hayami M, Shida H.

Virology. 2000 Apr 10;269(2):268-75.

PMID: 10753705 [PubMed - indexed for MEDLINE]

11:

Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.

Missé D, Gajardo J, Oblet C, Religa A, Riquet N, Mathieu D, Yssel H, Veas F.

AIDS. 2005 Jun 10;19(9):897-905.

PMID: 15905670 [PubMed - indexed for MEDLINE]

12:

In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies.

Marzio G, Verhoef K, Vink M, Berkhout B.

Proc Natl Acad Sci U S A. 2001 May 22;98(11):6342-7. Epub 2001 May 15.

PMID: 11353837 [PubMed - indexed for MEDLINE]

13:

Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine.

Berkhout B, Verhoef K, Marzio G, Klaver B, Vink M, Zhou X, Das AT.

J Neurovirol. 2002 Dec;8 Suppl 2:134-7. Review.

PMID: 12491165 [PubMed - indexed for MEDLINE]

14:

HIV-1 latency in actively dividing human T cell lines.

Jeeninga RE, Westerhout EM, van Gerven ML, Berkhout B.

Retrovirology. 2008 Apr 25;5:37.

PMID: 18439275 [PubMed - indexed for MEDLINE]

15:

Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes.

Gibbs JS, Regier DA, Desrosiers RC.

AIDS Res Hum Retroviruses. 1994 Apr;10(4):343-50.

PMID: 8068414 [PubMed - indexed for MEDLINE]

17:

HIV-induced T-cell syncytia release a two component T-helper cell chemoattractant composed of Nef and Tat.

Shutt DC, Soll DR.

J Cell Sci. 1999 Nov;112 ( Pt 22):3931-41.

PMID: 10547354 [PubMed - indexed for MEDLINE]

18:

Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.

Venzke S, Michel N, Allespach I, Fackler OT, Keppler OT.

J Virol. 2006 Nov;80(22):11141-52. Epub 2006 Aug 23.

PMID: 16928758 [PubMed - indexed for MEDLINE]

19:

The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest.

Sakai K, Dimas J, Lenardo MJ.

Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3369-74. Epub 2006 Feb 21.

PMID: 16492778 [PubMed - indexed for MEDLINE]

20:

Growth ability of auxiliary gene mutants of human immunodeficiency virus types 1 and 2 in unstimulated peripheral blood mononuclear cells.

Tokunaga K, Ishimoto A, Ikuta K, Adachi A.

Arch Virol. 1997;142(1):177-81.

PMID: 9155882 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 275
of 14Next